BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6436384)

  • 1. Influence of serum complement and rheumatoid factor on detection of immune complexes by the C1q and monoclonal rheumatoid factor solid-phase assay.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Immunol Methods; 1984 Oct; 73(2):301-11. PubMed ID: 6436384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference by rheumatoid factor and C1q in the detection of IgG complexes: studies of model systems by ELISA.
    Wager O; Lindstrøm P
    Scand J Immunol; 1982 Mar; 15(3):319-28. PubMed ID: 6979777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatitis herpetiformis: immune complex detection with C1q and monoclonal rheumatoid factor.
    Jordon RE; Tappeiner G; Kahl JC; Wolff K
    Br J Dermatol; 1981 Aug; 105(2):159-65. PubMed ID: 7025879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.
    Narumoto J
    Gastroenterol Jpn; 1981; 16(2):174-85. PubMed ID: 6971771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
    Medof ME
    J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current situation and problems in the estimation of circulating immune complexes].
    Yoshida H
    Rinsho Byori; 1992 Jan; 40(1):28-33. PubMed ID: 1545522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of immune complexes in systemic lupus erythematosus with the C1q solid phase assay: correlation with nDNA antibodies and hypocomplementemia.
    Agnello V; Mitamura T
    Clin Immunol Immunopathol; 1987 Mar; 42(3):338-43. PubMed ID: 3493866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
    Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
    Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factor.
    O'Sullivan MM; Amos N; Williams BD
    Ann Rheum Dis; 1988 Aug; 47(8):675-80. PubMed ID: 3261968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of ionic strength, EDTA concentration, endogenous C1q and polyanions on the 125I-C1q-binding test.
    Hack CE; Huijbregts CC; Paardekooper J
    J Immunol Methods; 1984 Aug; 72(1):197-206. PubMed ID: 6205096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of interaction between complement-fixing antibody/dsDNA immune complexes and erythrocytes. In vitro studies and potential general applications to clinical immune complex testing.
    Taylor RP; Horgan C; Hooper M; Burge J
    J Clin Invest; 1985 Jan; 75(1):102-11. PubMed ID: 3917462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IgG detected in the C1q solid-phase immune-complex assay is not always of immune-complex nature.
    Hack CE; Belmer AJ
    Clin Immunol Immunopathol; 1986 Jan; 38(1):120-8. PubMed ID: 3484437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and blister fluid immune complexes in bullous pemphigoid: detection with C1q and monoclonal rheumatoid factor.
    Jordon RE; Struve MF; Bushkell LL
    Clin Exp Immunol; 1981 Jul; 45(1):29-36. PubMed ID: 7030538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The modulation of immune complex aggregation by classical pathway-mediated reactions.
    Gronski P; Bodenbender L; Kanzy EJ; Loos M; Seiler FR
    Immunobiology; 1985 May; 169(4):346-61. PubMed ID: 3874147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1q solid-phase radioimmunoassay: binding properties of solid-phase C1q and evidence that C1q-binding IgG complexes in systemic lupus erythematosus are not bound to endogenous C1q.
    Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
    J Immunol Methods; 1984 Oct; 73(1):67-74. PubMed ID: 6436382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 125I-C1q binding activity of soluble antigen-antibody complexes formed in vitro.
    Soltis RD; Hasz DE
    J Clin Lab Immunol; 1982 Nov; 9(2):121-31. PubMed ID: 6984078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.